Is atomoxetine effective in some comorbid mental disorders in ADHD?

[1] American Psychiatric Association (APA). Disorders usually first diagnosed in infancy, childhood, or adolescence. Diagnostic and statistical manual of mental disorders, 4th edn, text revision. Washington, DC: American Psychiatric Association. 2000.Search in Google Scholar

[2] Bangs ME, Graham JE, Thomas JS et al.: Efficacy and safety of atomoxetine in adolescents with attention-deficit/hyperactivity disorder and major depression. J Child Adolesc Psychopharmacol. 2007;17(4):407-420.10.1089/cap.2007.006617822337Search in Google Scholar

[3] Barton, J. Atomoxetine: a new pharmacotherapeutic approach in the management of attention deficit/hyperactivity disorder. Arch Dis Child. 2005;90(suppl. L):126-129.10.1136/adc.2004.059386176527015665154Search in Google Scholar

[4] Biederman J, Faraone S, Milberger S et al. A prospective 4-year follow-up study of attention deficit hyperactivity and related disorders. Arch Gen Psychiatry. 1996;53:437-446.10.1001/archpsyc.1996.018300500730128624187Search in Google Scholar

[5] DeFillipis M, Wagner KD. Management of Treatment-Resistant Depression in Children and Adolescents. Pediatr Drugs. 2014;16:353-361.10.1007/s40272-014-0088-y25200567Search in Google Scholar

[6] Detke HC, DelBello MP, Landry J, Usher RW. Olanzapine/ Fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry. 2015;54(3):217-224. 10.1016/j.jaac.2014.12.01225721187Search in Google Scholar

[7] Emslie GJ, Heiligenstein JH, Wagner KD et al. Fluoxetine for acute treatment of depression in children and adolescents: a placebocontrolled, randomized clinical trial. J Am Acad Child Adolesc Psychiatry. 2002;41(10):1205-1215.10.1097/00004583-200210000-0001012364842Search in Google Scholar

[8] Emslie GJ, Rush AJ, Weinberg WA et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 1997;54(11):1031-1037.10.1001/archpsyc.1997.018302300690109366660Search in Google Scholar

[9] Emslie GJ, Kennard BD, Mayes TL et al. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry. 2008;165(4):459-467.10.1176/appi.ajp.2007.07091453282442918281410Search in Google Scholar

[10] Heiligenstein JH1, Hoog SL, Wagner KD et al. Fluoxetine 40-60 mg versus fluoxetine 20 mg in the treatment of children and adolescents with a less-than-complete response to nine-week treatment with fluoxetine 10-20 mg: a pilot study. J Child Adolesc Psychopharmacol. 2006;16(1-2):207-217.10.1089/cap.2006.16.20716553541Search in Google Scholar

[11] Hong JH, Novick D, Treuer T et al. Patient characteristics associated with treatment initiation among paediatric patients with Attention-Deficit/Hyperactivity Disorder symptoms in a naturalistic setting in Central Europe and East Asia. BMC Psychiatry. 2014;14:304.10.1186/s12888-014-0304-x421901525358916Search in Google Scholar

[12] Kennard BD, Emslie GJ, Mayes TL et al. Sequential treatment with fluoxetine and relapse prevention CBT to improve outcomes in pediatric depression. Am J Psychiatry. 2014;171(10).10.1176/appi.ajp.2014.13111460418211124935082Search in Google Scholar

[13] Kratochvil CJ, Newcorn JH, Arnold LE, et al. Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry. 2005;44(9):915-924. 10.1097/01.chi.0000169012.81536.3816113620Search in Google Scholar

[14] Ledbetter M. Atomoxetine: a novel treatment for child and adult ADHD. Neuropsychiatr Dis Treat. 2006; 2(4):455-466.10.2147/nedt.2006.2.4.455267195719412494Search in Google Scholar

[15] March J, Silva S, Petrycki S et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292(7):807-820.10.1001/jama.292.7.80715315995Search in Google Scholar

[16] Ondrejka I. Hyperkineticka porucha v detskom veku. Ceskoslovenska pediatria. 2007; 6:406-414.Search in Google Scholar

[17] Snircova E, Kulhan T, Ondrejka I, Nosalova G. Atomoxetine as treatment in comorbidity of ADHD. Pokroky vo farmakologii v Slovenskej republike. 2013;8:105-109.Search in Google Scholar

[18] Weiping X, Lixiao S, Jinsong Z. Comorbid anxiety and depression in school-aged children with attention deficit hyperactivity disorder (ADHD) and self reported symptoms of ADHD, anxiety, and depression among parents of school-aged children with and without ADHD. Shanghai Arch Psychiatry. 2015; 25; 27(6):356-367.Search in Google Scholar

[19] Zerbe RL, Rowe H, Enas CG et al. Clinical pharmacology of tomoxetine, a potential antidepressant. J Pharmacol Exp Ther. 1985;232:139-143. Search in Google Scholar